S-propargyl-cysteine is reported to promote PI3K/AKT/Nrf2/HO-1 pathway activation, conferring an antioxidative effect to prevent from methionine and choline-deficient diet-induced NAFLD mice [19]. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.